Nothing to go for at the moment. In fact the delay in patient recruitment for the Bronchitol trial in the US is bad news. Plus it seems from the notes that Pharmaxis is on the hook for $3m of costs (more to come ??) on that trial.
Unless something comes left field, this could be heading back to 22-23c.
- Forums
- ASX - By Stock
- YAWN
Nothing to go for at the moment. In fact the delay in patient...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
-0.002(4.65%) |
Mkt cap ! $56.29M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 4.0¢ | $121.5K | 3.004M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 649826 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 959182 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 649826 | 0.040 |
2 | 775599 | 0.039 |
3 | 98944 | 0.038 |
2 | 600000 | 0.037 |
3 | 526642 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 959182 | 2 |
0.043 | 149998 | 4 |
0.044 | 606744 | 6 |
0.045 | 1000250 | 4 |
0.046 | 1177418 | 4 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online